Vancouver, BC — December 14, 2018 — /D.M.O. Newswire/ — Harvest One Cannabis Inc. (TSXV: HVT) (“Harvest One” or the “Company”) immediately introduced that the Board of Directors (the “Board”) has named Mr. Frank Holler as Chairman efficient instantly. Mr. Holler first joined the Board as a Director in September 2018. Peter Wall, Harvest One’s former Chairman of the Board, will stay on the Board as a Director.
Grant Froese, Harvest One’s CEO commented, “Frank’s experience, particularly in the pharmaceutical industry and capital markets, strengthens the depth of expertise on the Harvest One Board. We’re delighted he’s stepping in as Chairman as this further sets us up for a landmark year in 2019.”
Mr. Holler, who’s President and CEO of Ponderosa Capital Inc., is an knowledgeable in biotechnology, funding banking and enterprise capital. He beforehand served as CEO and Partner of Lions Capital Corp., fund supervisor for BC Advantage Funds and the Lions Funds; as President and CEO of Xenon Pharmaceuticals Inc., a personal genomics-based drug growth firm; as President and CEO of ID Biomedical Corporation, a vaccine growth firm offered to GlaxoSmithKline plc; and as a founding director of Angiotech Pharmaceuticals, a TSX/ NASDAQ listed medical gadget firm. Before working in biotechnology and healthcare, Mr. Holler was an Investment Banker with Merrill Lynch Canada and Wood Gundy Inc. (now CIBC World Markets).
At the Board assembly Mr. Froese thanked departing Chairman Peter Wall for his service, saying: “On behalf of the Board, I would like to thank Peter for his contributions to Harvest One over the past few years and we’re pleased he’s staying on as a Director.”
About Harvest One Cannabis Inc. (TSXV: HVT)
Harvest One is a world hashish firm that develops and gives progressive life-style and wellness merchandise to customers and sufferers in regulated markets round the world. The Company’s vary of life-style options is designed to boost high quality of life. Shareholders have vital publicity to the whole hashish worth chain by three wholly-owned subsidiaries; United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); and Dream Water Global (client), and a minority curiosity in Burb Cannabis (retail operations). For extra info, please go to www.harvestone.com.
Certain statements contained on this press launch represent forward-looking info. These statements relate to future occasions or future efficiency. The use of any of the phrases “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and related expressions and statements referring to issues that aren’t historic info are supposed to establish forward-looking info and are primarily based on the Company’s present perception or assumptions as to the end result and timing of such future occasions. Actual future outcomes could differ materially. The forward-looking info contained on this press launch is made as of the date hereof, and the Company shouldn’t be obligated to replace or revise any forward-looking info, whether or not as a outcome of new info, future occasions or in any other case, besides as required by relevant securities legal guidelines. Because of the dangers, uncertainties and assumptions contained herein, buyers mustn’t place undue reliance on forward-looking info. The foregoing statements expressly qualify any forward-looking info contained herein.
Neither TSX-V nor its Regulation Services Provider (as that time period is outlined in the insurance policies of the TSX-V) settle for accountability for the adequacy or accuracy of this launch.
Get Real-Time Updates from The Daily Marijuana Observer